REZDIFFRA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
82576-080 -
Package NDC
82576-080-30 -
Package NDC
82576-080-90 -
Application number
NDA217785 -
SPL ID
1fec1a4b-28d9-41c3-ae32-59b53cd41f07 -
SPL set ID
e67ea09f-a840-439c-86c8-f98585f978b2 -
UNII
RE0V0T1ES0 -
RxCUI
2677899 -
RxCUI
2677905 -
RxCUI
2677907 -
RxCUI
2677909 -
RxCUI
2677911 -
RxCUI
2677913
What the source publishes
- Labeler
- Madrigal Pharmaceuticals, Inc.
- Active ingredients
- resmetirom
- Form
- TABLET, COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "REZDIFFRA",
"splId": "1fec1a4b-28d9-41c3-ae32-59b53cd41f07",
"labels": [
{
"setId": "e67ea09f-a840-439c-86c8-f98585f978b2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e67ea09f-a840-439c-86c8-f98585f978b2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e67ea09f-a840-439c-86c8-f98585f978b2"
}
],
"routes": [
"ORAL"
],
"labeler": "Madrigal Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, COATED in 1 BOTTLE (82576-080-30)",
"package_ndc": "82576-080-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20240314"
},
{
"sample": false,
"description": "90 TABLET, COATED in 1 BOTTLE (82576-080-90)",
"package_ndc": "82576-080-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20240314"
}
],
"productId": "82576-080_1fec1a4b-28d9-41c3-ae32-59b53cd41f07",
"useDomain": "unknown",
"dosageForm": "TABLET, COATED",
"productNdc": "82576-080",
"deaSchedule": null,
"genericName": "resmetirom",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RESMETIROM",
"strength": "80 mg/1"
}
],
"applicationNumber": "NDA217785",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240314",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000194131",
"N0000194132",
"N0000187062",
"N0000190107",
"N0000190108",
"N0000190113"
],
"upc": [
"0382576060306"
],
"unii": [
"RE0V0T1ES0"
],
"rxcui": [
"2677899",
"2677905",
"2677907",
"2677909",
"2677911",
"2677913"
],
"spl_set_id": [
"e67ea09f-a840-439c-86c8-f98585f978b2"
],
"pharm_class_epc": [
"Thyroid Hormone Receptor beta Agonist [EPC]"
],
"pharm_class_moa": [
"Thyroid Hormone Receptor beta Agonists [MoA]",
"Cytochrome P450 2C8 Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
"Breast Cancer Resistance Protein Inhibitors [MoA]"
],
"manufacturer_name": [
"Madrigal Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:82576-080_1fec1a4b-28d9-41c3-ae32-59b53cd41f07"